Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D003453:Cryptococcosis / Q000188:drug therapy*; D003454:Cryptococcus; D003455:Cryptococcus neoformans; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007278:Injections, Spinal; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D008875:Middle Aged
D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine